Cochlear Ltd
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades.
The business
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Small Caps Research
No research on Cochlear Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise COH based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Bad news drags Australian market lower as oil cracks US$100 again
ASX 200 slips 0.8% as oil rebounds above US$100; tech shares crash on AI cost fears, while energy names rise on higher oil prices.
Gold surge helps ASX to a weekly rise
Gold rally fuels ASX weekly gain as miners surge; Catalyst Metals +19%, Genesis Minerals +16%, Newmont +5%, Fortescue slips on China move.
Weekly wrap: ASX loses steam amid hairy chested war rhetoric
ASX slips as Trump-Iran tension persists; IGO sinks 18% on lithium gloom, while energy stocks rally; weekly loss about 1.8%.
Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal
Australia’s competition watchdog, the Australian Competition and Consumer Commission (ACCC) declared it has “significant preliminary competition concerns” regarding Cochlear’s (ASX: COH) proposed $170 million acquisition of Oticon Medical. Cochlear and Oticon Medical manufacture and distribute non-surgical bone conduction devices, surgical bone anchored devices, and cochlear implant hearing devices. The ACCC released a statement fearing the […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.